The purpose of breast cancer screening is to find cancers early to reduce mortality and to allow successful treatment with less aggressive therapy. Mammography is the gold standard for breast cancer screening. Its efficacy in reducing mortality from breast cancer was proven in randomized controlled trials (RCTs) conducted from the early 1960s to the mid 1990s. Panels that recommend breast cancer screening guidelines have traditionally relied on the old RCTs, which did not include considerations of breast density, race/ethnicity, current hormone therapy, and other risk factors. Women do not all benefit equally from mammography. Mortality reduction is significantly lower in women with dense breasts because normal dense tissue can mask cancers on mammograms. Moreover, women with dense breasts are known to be at increased risk. To provide equity, breast cancer screening guidelines should be created with the goal of maximizing mortality reduction and allowing less aggressive therapy, which may include decreasing the interval between screening mammograms and recommending consideration of supplemental screening for women with dense breasts. This review will address the issue of dense breasts and the impact on the stage of breast cancer at the time of diagnosis, and discuss options for supplemental screening.
News: Is Relatively Pain-free Cancer Treatment Now Possible?
Kaplan-Meier curves showing the cumulative incidence of recurrence
Game Pass alternative EA Access is now just 79p for one month
Cancer Reports - Wiley Online Library
Current Oncology MDPI
Oncology Times, February 10 2016 Vol.38 Issue 3
Oncology Times, October 25 2016 Vol.38 Issue 20
Recent Developments In Endometrial Cancer Research, 42% OFF
Current Oncology, Free Full-Text
Survey of undergraduate medical students on their understanding and attitude towards the discipline of radiotherapy – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on
Current Oncology 2022 - Browse Issues